Tags: academic health centers, antonio m gotto, antonio m gotto jr, antonio m gotto jr md, arthur rubenstein, cornell university, dean school, decision memo, health sciences university, letter dated august, medicaid services, medicare medicaid, oklahoma state university, oklahoma state university center for health sciences, philip a pizzo, philip a pizzo md, suzanne weiss dean, university of california irvine, university of cincinnati, weill medical college,
Steven A. Wartman, MD, PhD August 16, 2007
President/CEO
Board of Directors
Steve Phurrough, MD, MPA
Michael V. Drake, MD
Chancellor Director Coverage & Analysis Group
University of California, Irvine Centers for Medicare & Medicaid Services
Chair
Office of Clinical Standards & Quality
Arthur Rubenstein, MBBCh
Executive Vice President for the
Director, Coverage & Analysis Group
Health System ATTN: Clinical Study Certification
Dean, School of Medicine
University of Pennsylvania Mailstop: C1-09-26
Chair-Elect 7500 Security Blvd
Frank B. Cerra, MD Baltimore, MD 21244
Senior Vice President
for Health Sciences
University of Minnesota Re: Proposed Decision Memo for Clinical Trial Policy (CAG-00071R2)
Immediate Past Chair
John Fernandes, DO, MBA Dear Dr. Phurrough:
President
Oklahoma State University
Center for Health Sciences On behalf of the Association of Academic Health Centers (AAHC), I
Antonio M. Gotto, Jr., MD, DPhil would like to thank the Centers for Medicare & Medicaid Services
Stephen and Suzanne Weiss Dean (CMS) for providing the opportunity to discuss the proposed clinical
and Provost, Medical Affairs
Weill Medical College and Graduate research policy (CRP) and hear the perspectives from agency
School of Medical Sciences
Cornell University administrators at the August 7, 2007 Special Open Door Forum. In
light of those discussions, we would like to emphasize and expand on a
Jane E. Henney, MD
Senior Vice President and number of issues raised in our earlier comment letter, dated August 6,
Provost for Health Affairs 2007.
University of Cincinnati
Philip A. Pizzo, MD
Dean, School of Medicine
The AAHC, a national, non-profit association representing more than
Stanford University 100 academic health centers nationwide, is dedicated to improving the
Sheldon M. Retchin, MD, MSPH nation's health care system by mobilizing and enhancing the strengths
Chief Executive Officer VCU Health
System, Vice President for Health
and resources of the academic health center enterprise in health
Sciences professions education, patient care, and research.
Virginia Commonwealth University
Fred Sanfilippo, MD, PhD As stated in our earlier letter, the AAHC strongly recommends that the
Senior Vice President and
Executive Dean for Health Sciences policy implementation date be decided upon based on the date of
Chief Executive Officer, OSU Medical initial IRB approval rather than the date of patient enrollment. The
Center
The Ohio State University date of the first enrollment is not the milestone event in clinical trial
Larry J. Shapiro, MD administrative and billing processes. Using this marker may mean that
President, Washington University studies that already have IRB approval will need to be re-reviewed and
Medical Center, Executive Vice
Chancellor for Medical Affairs and approved again by the IRB. All institutions track IRB approvals; few
Dean, School of Medicine track enrollment dates. Thus, all studies with an initial IRB approval on
Washington University
or before the effective implementation date should be covered under
Andrew A. Sorensen, PhD the old Clinical Trial Policy and any studies without initial IRB approval
President
University of South Carolina should be subject to the new Clinical Research Policy.
1400 16th Street, NW, Suite 720
Washington, DC 20036
P 202.265.9600 F 202.265.7514 Strengthen. Advocate. Lead.
www.aahcdc.org
Dr. Steve Phurrough
Page 2
August 16, 2007
The AAHC would now additionally recommend that to provide clarity and consistency
throughout the policy, CMS use "date of initial Institutional Review Board
approval" in several sections of the proposed CRP. These sections are:
1. The first sentence of the NCD Manual 310.1: Clinical Research Policy, which
would then read: "Medicare covers usual patient care in a clinical research
study initially approved by an Institutional Review Board as of October 17,
2007." [Presuming the final policy is issued on this date.]
2. Under the approval process section of the proposed policy: the description of
the information that should be included in the certification letter should be
changed to read the "date of initial IRB approval" rather than "study start
date."
3. Proposed standard bullet #10 should be changed to read: "The clinical
research study is registered on the ClinicalTrials.gov web site by the study
sponsor/principal investigator, or designee of the principal investigator, after
initial IRB approval."
Finally, to ameliorate the administrative burden during the transition from the
current Clinical Trial Policy to the new Clinical Research Policy, the AAHC suggests
CMS consider a process that would permit, at the institution's discretion, clinical
research studies begun prior to the effective date of the final CRP to be brought
under the new policy. This would occur by fulfilling the requirements of
ClinicalTrials.gov registration and submission of the certification letter to CMS.
Thank you for considering these recommendations which were developed by
members of the AAHC's Forum on Regulation, comprising chief compliance officers
from academic health centers nationwide. The AAHC looks forward to continuing to
work with CMS and stands ready to assist in any capacity.
Sincerely,
Steven A. Wartman, MD, PhD, MACP
President/CEO
CC: Leslye K. Fitterman